Literature DB >> 6795124

Activation of the alternative complement pathway by Trichomonas vaginalis.

F D Gillin, A Sher.   

Abstract

The mechanism underlying the lysis of Trichomonas vaginalis by normal human or guinea pig serum was investigated. The involvement of the complement system was demonstrated by the failure of human serum deficient in C3 or C8 to mediate parasite killing and by the ablation of lytic activity observed when fresh sera were heated at 56 degrees C or treated with ethylenediaminetetraacetate. Fixation of human C3 on the parasite surface was demonstrated by indirect immunofluorescence. The involvement of the alternative complement pathway was demonstrated (i) by the inability of properdin-depleted human serum to lyse T. vaginalis and (ii) by the normal killing observed with guinea pig serum lacking C4 and with normal human or guinea pig serum treated with ethylene glycol-bis(beta-aminoethyl ether)-N,N-tetraacetic acid and Mg2+ to selectively inhibit the classical pathway.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6795124      PMCID: PMC350852          DOI: 10.1128/iai.34.1.268-273.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  A factor in serum of human beings and animals that destroys T. vaginalis.

Authors:  J T WELD; B H KEAN
Journal:  Proc Soc Exp Biol Med       Date:  1958-07

Review 2.  Activation of the alternative complement pathway.

Authors:  D T Fearon
Journal:  CRC Crit Rev Immunol       Date:  1979-11

3.  Interactions between Entamoeba histolytica and complement.

Authors:  G Huldt; P Davies; A C Allison; H U Schorlemmer
Journal:  Nature       Date:  1979-01-18       Impact factor: 49.962

4.  Activation of the alternative pathway of complement by Entamoeba histolytica.

Authors:  L Ortiz-Ortiz; R Capin; N R Capin; B Sepúlveda; G Zamacona
Journal:  Clin Exp Immunol       Date:  1978-10       Impact factor: 4.330

5.  Proteins of cervical mucus.

Authors:  M Elstein; A C Pollard
Journal:  Nature       Date:  1968-08-10       Impact factor: 49.962

6.  Trichomonacidal activity of human polymorphonuclear neutrophils: killing by disruption and fragmentation.

Authors:  M F Rein; J A Sullivan; G L Mandell
Journal:  J Infect Dis       Date:  1980-10       Impact factor: 5.226

7.  Genetically controlled total deficiency of the fourth component of complement in the guinea pig.

Authors:  L Ellman; I Green; M Frank
Journal:  Science       Date:  1970-10-02       Impact factor: 47.728

8.  Mechanism of lethal effect of human serum upon Leishmania donovani.

Authors:  R D Pearson; R T Steigbigel
Journal:  J Immunol       Date:  1980-11       Impact factor: 5.422

9.  The role of immunoglobulins in alternative complement pathway activation by zymosan. I. Human IgG with specificity for Zymosan enhances alternative pathway activation by zymosan.

Authors:  H A Schenkein; S Ruddy
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

10.  Studies on the selective lysis and purification of Trypanosoma cruzi.

Authors:  N Nogueira; C Bianco; Z Cohn
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

View more
  13 in total

Review 1.  Target recognition failure by the nonspecific defense system: surface constituents of pathogens interfere with the alternative pathway of complement activation.

Authors:  R D Horstmann
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

2.  Properties of Trichomonas vaginalis grown under chemostat controlled growth conditions.

Authors:  M W Lehker; J F Alderete
Journal:  Genitourin Med       Date:  1990-06

3.  Antibody enhances killing of Tritrichomonas foetus by the alternative bovine complement pathway.

Authors:  M K Aydintug; R W Leid; P R Widders
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

4.  Immunoglobulin M-dependent classical complement pathway activation in killing of Pentatrichomonas hominis.

Authors:  M F Shaio; J G Chen
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

Review 5.  Clinical and microbiological aspects of Trichomonas vaginalis.

Authors:  D Petrin; K Delgaty; R Bhatt; G Garber
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

6.  Characterization of Tritrichomonas foetus antigens by use of monoclonal antibodies.

Authors:  J L Hodgson; D W Jones; P R Widders; L B Corbeil
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

7.  Lysis of complement-sensitive Entamoeba histolytica by activated terminal complement components. Initiation of complement activation by an extracellular neutral cysteine proteinase.

Authors:  S L Reed; I Gigli
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

8.  Differential susceptibility of fresh Trichomonas vaginalis isolates to complement in menstrual blood and cervical mucus.

Authors:  P Demes; A Gombosová; M Valent; A Jánoska; H Fabusová; M Petrenko
Journal:  Genitourin Med       Date:  1988-06

9.  Heterogeneity of Trichomonas vaginalis and discrimination among trichomonal isolates and subpopulations with sera of patients and experimentally infected mice.

Authors:  J F Alderete; L Suprun-Brown; L Kasmala; J Smith; M Spence
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

10.  Host plasma proteins on the surface of pathogenic Trichomonas vaginalis.

Authors:  K M Peterson; J F Alderete
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.